NOTA:FRA
Novartis AG
€123.00
0.00%
(0.00) 1D
Oct 5, 8:03:05 AM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOTA...
Mkt. cap
285.56B
Avg. vol.
27.00
Volume
0.00
52-wk high
€145.00
52-wk low
€102.50
No. of employees
75K
Mkt. cap
285.56B
Avg. vol.
27.00
Volume
0.00
52-wk high
€145.00
52-wk low
€102.50
No. of employees
75K
News stories
From web sources and news partners
AD HOC NEWS
·
8 minutes ago
Novartis stock pre-market at EUR 124.76: minus 0.42 percent
AD HOC NEWS
·
14 hours ago
Novartis stock gets a USD 575 million mRNA deal
Zacks Investment Research
·
14 hours ago
Novartis Strengthens RNA Therapeutics Pipeline With $7.8B Abogen Deal
TradingView
·
21 hours ago
Novartis India share price jumps 10% | What lies ahead for the stock?
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75.3K
FoundedMar 7, 1996
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websitenovartis.com